These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1427998)
1. In vitro bioassay for type E prostaglandins based on their NK immunodepressing activity. Kluchareva TE; Matveeva VA; Kushlinsky NE Immunol Lett; 1992 Aug; 33(3):239-45. PubMed ID: 1427998 [TBL] [Abstract][Full Text] [Related]
2. [Secretion of prostaglandin type E (PGE) by tumor cells of Syrian hamsters in in vitro contact with natural killers]. Kliuchareva TE; Matveeva VA; Bassalyk AS; Kushlinskiĭ NE Biull Eksp Biol Med; 1988 Feb; 105(2):204-6. PubMed ID: 3349152 [TBL] [Abstract][Full Text] [Related]
3. Relative immunosuppressive activity of human seminal prostaglandins. Skibinski G; Kelly RW; Harrison CM; McMillan LA; James K J Reprod Immunol; 1992 Aug; 22(2):185-95. PubMed ID: 1501205 [TBL] [Abstract][Full Text] [Related]
4. [Effect of the prostaglandin E produced by tumor cells on the enzymatic activity of adenosine metabolism and on human natural killer cytotoxic activity]. Umanskiĭ VIu; Kliuchareva TE; Matveeva VA Eksp Onkol; 1989; 11(3):60-3. PubMed ID: 2546731 [TBL] [Abstract][Full Text] [Related]
5. [Secretion of type-E prostaglandin by tumor cells of different degrees of malignancy when in contact with effectors of natural resistance]. Kliuchareva TE; Matveeva VA; Kashkina LM; Kushlinskiĭ NE; Bassalyk LS Eksp Onkol; 1989; 11(1):53-6. PubMed ID: 2924711 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain. Joshi PC; Zhou X; Cuchens M; Jones Q J Immunol; 2001 Jan; 166(2):885-91. PubMed ID: 11145664 [TBL] [Abstract][Full Text] [Related]
7. The modulation of human natural killer cell activity by prostaglandins. Bankhurst AD J Clin Lab Immunol; 1982 Feb; 7(2):85-91. PubMed ID: 6951051 [TBL] [Abstract][Full Text] [Related]
8. [Sensitivity of tumor cells to cytostatic action of NK cells and their capacity of releasing prostaglandin E]. Kliuchareva GE; Matveeva VA; Uvarova EN Biull Eksp Biol Med; 1990 Sep; 110(9):308-10. PubMed ID: 2268725 [TBL] [Abstract][Full Text] [Related]
9. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. Lala PK; Parhar RS; Singh P Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621 [TBL] [Abstract][Full Text] [Related]
10. [Secretion of prostaglandin E by cells of human thymoma MOLT-4 and their sensitivity to cytotoxic action of NK-cells]. Kliuchareva TE; Matveeva VA; Kushlinskiĭ NE; Uvarova EN Biull Eksp Biol Med; 1990 Aug; 110(8):204-6. PubMed ID: 2291974 [TBL] [Abstract][Full Text] [Related]
11. Antioxidant defence mechanisms and PGE secretion by different types of transformed and tumor cells: in vivo selective advantages. Deichman GI; Kashkina LM; Kluchareva TE; Matveeva VA; Uvarova EN; Burdelya LG Adv Exp Med Biol; 1997; 400A():473-7. PubMed ID: 9547592 [No Abstract] [Full Text] [Related]
12. Regulation of human natural cytotoxicity by IgG. II. Cyclic AMP as a mediator of monomeric IgG-induced inhibition of natural killer cell activity. Bancu AC; Gherman M; Sulica A; Goto T; Farrar W; Herberman RB Cell Immunol; 1988 Jul; 114(2):246-56. PubMed ID: 2455604 [TBL] [Abstract][Full Text] [Related]
13. [The secretion of type-E prostaglandins and the sensitivity to hydrogen peroxide of Syrian hamster clone cells transformed by the Rous sarcoma virus]. Kashleva EA; Matveeva VA; Uvarova EN; Kliuchareva TE Eksp Onkol; 1990; 12(5):32-4. PubMed ID: 2171899 [TBL] [Abstract][Full Text] [Related]
14. [The role of prostaglandins type E in tumor cells during their contact with NK-cells in vitro]. Matveeva VA; Kliuchareva TE; Uvarova EN Biull Eksp Biol Med; 1993 Feb; 115(2):193-4. PubMed ID: 8043806 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Yakar I; Melamed R; Shakhar G; Shakhar K; Rosenne E; Abudarham N; Page GG; Ben-Eliyahu S Ann Surg Oncol; 2003 May; 10(4):469-79. PubMed ID: 12734098 [TBL] [Abstract][Full Text] [Related]
16. Discrimination between NK and LAK cytotoxic activities of murine spleen cells by MTT assay: differential inhibition by PGE(2) and EDTA. Ribeiro-Dias F; Marzagão Barbuto JA; Tsujita M; Jancar S J Immunol Methods; 2000 Jul; 241(1-2):121-9. PubMed ID: 10915854 [TBL] [Abstract][Full Text] [Related]
17. Cortisol at physiological concentrations and prostaglandin E2 are additive inhibitors of human natural killer cell activity. Gatti G; Cavallo R; Sartori ML; Marinone C; Angeli A Immunopharmacology; 1986 Apr; 11(2):119-28. PubMed ID: 2423476 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 depresses natural cytotoxicity by inhibiting interleukin-1 production by large granular lymphocytes. Herman J; Rabson AR Clin Exp Immunol; 1984 Aug; 57(2):380-4. PubMed ID: 6331926 [TBL] [Abstract][Full Text] [Related]
19. Modulation of mouse spleen natural killer (NK) cell activity by beta-interferon, interleukin-1, and prostaglandins. Voiculescu CL; Rosu L; Rogoz S Lymphology; 1988 Sep; 21(3):144-51. PubMed ID: 3264360 [TBL] [Abstract][Full Text] [Related]